,30,31,32,33,34,35,36 Among them, ABTB2 has gained attention for its involvement in PTEN-dependent tumor suppression in ovarian tumors and its association with drug resistance in breast and thyroid cancers,37,38 highlighting its relevance across multiple cancer contexts. This evidence concerns the gene PTEN and ovarian neoplasm.